Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 49.45
-5.35 (-9.76%)
At close: Mar 27, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 2.53 billion as of March 27, 2026. Its market cap has decreased by -18.65% in one year.
Market Cap
2.53B
Enterprise Value
2.39B
Revenue
222.03M
Ranking
n/a
PE Ratio
107.50
Stock Price
49.45
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 2.53B, an increase of 81.89%. That is a compound annual growth rate of 43.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 2.53B | -29.36% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Otsuka Information Technology | 2.85B |
| Tera Autotech | 2.85B |
| Magnate Technology | 2.84B |
| Kaofu Chemical | 2.84B |
| Gigastone | 2.83B |
| Cheng Fwa Industrial | 2.81B |
| eGalax_eMPIA Technology | 2.81B |
| Calitech | 2.80B |